Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients-Reference-Cited by-同舟云学术

Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients

Published:2016-11-21 Issue:4 Volume:140 Page:973-982
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Miyazawa Motoki¹,Katsuda Masahiro¹,Maguchi Hiroyuki²,Katanuma Akio²,Ishii Hiroshi³,Ozaka Masato³,Yamao Kenji⁴,Imaoka Hiroshi⁴,Kawai Manabu¹,Hirono Seiko¹,Okada Ken-ichi¹,Yamaue Hiroki¹

Affiliation:

1. Second Department of Surgery; Wakayama Medical University School of Medicine, Japan

2. Center for Gastroenterology, Teine-Keijinkai Hospital, Japan

3. Department of Gastroenterology; Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan

4. Department of Gastroenterology; Aichi Cancer Center Hospital, Japan

Funder

Health and Labour Sciences Research Grants of the Ministry of Health Labour and Welfare in Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

3. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

4. European Study Group for Pancreatic Cancer. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial;Neoptolemos;JAMA,2010

5. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer;Ueno;Br J Cancer,2009

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance;Current Cancer Drug Targets;2024-11

2. Advancing Cancer Therapy: The Role of KIF20A as a Target for Inhibitor Development and Immunotherapy;Cancers;2024-08-24

3. Clinical immunotherapy in pancreatic cancer;Cancer Immunology, Immunotherapy;2024-03-02

4. Immune modulators for pancreatic ductal adenocarcinoma therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024

5. Current status of vaccine immunotherapy for gastrointestinal cancers;Surgery Today;2023-12-03